Letter from Founder
Dear patients, medical practitioners, and members of the public:
From the outset of our activities, our vision was, and continues to be, to make a noticeable contribution to mankind. I believe that the results of our hard work of developing devices that bring advanced technology into the body, has brought us a long way on our path to fulfilling that vision. Today, I am proud to release the results of many years of intensive work within Implantica.
We present our innovative Intelligent eHealth & Wireless Energizing Platforms. Our advanced new system is designed to allow monitoring, energizing, controlling and adjusting eHealth devices including smart medical implants by the caregiver on distance.
We now present our innovative Smart eHealth and Intelligent Wireless Energizing Platforms, e-InVivo™. Our advanced new system is designed to allow monitoring, controlling and adjusting treatment of Smart eHealth implantable devices on distance. The key elements of the platform are its security features making it possible for such treatment control on distance. We believe that our platform has the potential to completely change the treatment of many common conditions. We target to launch several patented medical implants, allowing the development and production of the next generation of smart medical implants. In the future, healthcare has the potential to be more proactive by enabling early detection and monitoring of many different conditions, which will only be possible with advanced technology entering the body. Implantica’s eHealth platform e-InVivo is subject to further development and approval process.
RefluxStopTM has the potential to create a paradigm shift in the treatment of acid reflux, based on its 5-year clinical results from the CE study.
The clinical results of the RefluxStop procedure have been excellent, both in our 5-year study and the real-world experience. Through our very successful experience with developing and marketing the SAGB gastric band, where we managed to take 28% market share of all obesity surgery outside the U.S., we have gained invaluable experience of how to develop a medical implant business. RefluxStop, obtained CE mark approval in 2018, and has the potential to create a paradigm shift in the treatment of acid reflux purely based on clinical results.
We predict healthcare will take a leap when advanced technology enters the body, in the same way that advanced technology has changed our daily lives.
We predict healthcare will take a leap when advanced technology enters the body, in the same way that advanced technology has changed our daily lives. Our platform technologies and products are being designed to bring much-needed relief for suffering individuals, while substantially reducing the economic burden on society.
Yours sincerely,
Peter Forsell
CEO Implantica and Founder
Specialist in General Surgery and Inventor